Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Corvus Pharmaceuticals (CRVS) stocks in Canada
Learn how to easily invest in Corvus Pharmaceuticals stocks.
Corvus Pharmaceuticals is a biotechnology business based in the US. Corvus Pharmaceuticals stocks (CRVS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.68 – a decrease of 21.33% over the previous week. Corvus Pharmaceuticals employs 42 staff and has a market cap (total outstanding stock value) of $104.7 million.
How to buy shares in Corvus Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRVS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Corvus Pharmaceuticals?
- Has coronavirus impacted Corvus Pharmaceuticals shares?
- Corvus Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Corvus Pharmaceuticals stock a buy or sell?
- Corvus Pharmaceuticals performance over time
- Corvus Pharmaceuticals's financials
- How volatile are Corvus Pharmaceuticals shares?
- Does Corvus Pharmaceuticals pay a dividend?
- Other common questions
Corvus Pharmaceuticals stock price (NASDAQ:CRVS)Use our graph to track the performance of CRVS stocks over time.
Corvus Pharmaceuticals shares at a glance
|Latest market close||$1.77|
|52-week range||$1.86 - $9.54|
|50-day moving average||$3.11|
|200-day moving average||$3.15|
|Wall St. target price||$6.38|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.18|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Corvus Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Corvus Pharmaceuticals price performance over time
|1 week (2022-01-14)||-21.33%|
|1 month (2021-12-23)||-35.16%|
|3 months (2021-10-22)||-60.40%|
|6 months (2021-07-23)||-21.33%|
|1 year (2021-01-22)||-56.30%|
|2 years (2020-01-24)||-69.54%|
|3 years (2019-01-24)||3.86|
|5 years (2017-01-24)||13.86|
Corvus Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-29.75%|
|Return on equity TTM||-9.03%|
|Market capitalisation||$104.7 million|
TTM: trailing 12 months
Corvus Pharmaceuticals share dividends
We're not expecting Corvus Pharmaceuticals to pay a dividend over the next 12 months.
Corvus Pharmaceuticals share price volatility
Over the last 12 months, Corvus Pharmaceuticals's shares have ranged in value from as little as $1.86 up to $9.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Corvus Pharmaceuticals's is 0.8662. This would suggest that Corvus Pharmaceuticals's shares are less volatile than average (for this exchange).
Corvus Pharmaceuticals overview
Corvus Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial that inhibits the production of adenosine and activate various immune cells, as Phase III clinical trial of CPI-006 for COVID-19. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase Ib/II clinical trial for adenosine, an immune checkpoint. Its preclinical stage products include CPI-182, an antibody to block neutrophil function and migration, and myeloid derived suppressor cells; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines.
Stocks similar to Corvus Pharmaceuticals
Corvus Pharmaceuticals in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.